Ultrasound joint health study for mild hemophilia
Part of Blood & lymphatic, Bones, joints & muscles, Genetic & congenital clinical trials.
This study uses ultrasound to check the health of joints in adults with mild hemophilia. It may help doctors understand how to better care for people with this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have mild hemophilia A or B (your clotting factor level is between 5% and 40%).
- You are not taking any preventive clotting factor treatments (like regular injections or emicizumab).
- You do not have acquired hemophilia (hemophilia that started later in life).
- You do not have an uncontrolled condition that affects your joints (like active rheumatoid arthritis).
- You are not pregnant, breastfeeding, or legally unable to make your own medical decisions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at how well joint health can be tracked in people with severe hemophilia A who are receiving regular factor VIII treatment. It uses special markers in the blood and ultrasound to check for early joint changes.
This study checks joint health and bleeding risk in people with severe hemophilia A who are taking newer factor VIII treatments or emicizumab. It uses ultrasound and blood tests to see how well these therapies protect joints.
This study uses ultrasound to check if thickened joint lining (synovium) in people with severe hemophilia is a sign of active inflammation or just a harmless leftover. It may help doctors decide whether to treat or watch these joints.
This trial uses ultrasound to check if healthy joints in people with hemophilia A develop damage while being treated with emicizumab (Hemlibra). It looks at elbows, knees, and ankles over time to see if the medicine prevents joint problems.
This study looks at how many adults with moderate or severe hemophilia A have inflammation in their joints (synovitis). It aims to better understand joint health in people with hemophilia A, including those with inhibitors or joint replacements.
This study checks how well efanesoctocog alfa (a preventive factor VIII treatment) protects your joints over time in people with hemophilia A. It involves regular checkups, joint assessments, and tracking of any bleeding episodes.
Hear when a new Mild Hemophilia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.